Noticias TransCode Therapeutics Inc - RNAZ | Acciones NASDAQ

Discusiones en tiempo real e ideas comerciales: opere con confianza con nuestra poderosa plataforma.

Premium

Form 4 - Statement of changes in beneficial ownership of securities

Form 8-K/A - Current report: [Amend]

Form 8-K - Current report

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material

Nasdaq Determines That TransCode Therapeutics Has Regained Compliance with Continued Listing Requirements

BOSTON, June 10, 2024 (GLOBE NEWSWIRE) -- TransCode Therapeutics, Inc. (Nasdaq: RNAZ), (the “Company”), an...

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material

Form 8-K - Current report

TransCode Therapeutics Reports Positive Data from First-in-Human Clinical Study Using Novel Lead Therapeutic Candidate, TTX-MC138

BOSTON, May 29, 2024 (GLOBE NEWSWIRE) -- TransCode Therapeutics, Inc. (NASDAQ: RNAZ), the RNA oncology...

Form DEFR14A - Revised definitive proxy soliciting materials

Form 8-K - Current report

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material

TransCode Therapeutics Open Letter to Shareholders

BOSTON, May 13, 2024 (GLOBE NEWSWIRE) -- The Board and Management of TransCode Therapeutics (NASDAQ: RNAZ...

Form PRE 14A - Other preliminary proxy statements

Form 8-K - Current report

TransCode Therapeutics Announces FDA Clearance To Initiate Phase 1/2 Clinical Trial with TTX-MC138 in Patients with Advanced Solid Tumors

BOSTON, April 15, 2024 (GLOBE NEWSWIRE) -- TransCode Therapeutics, Inc. (NASDAQ: RNAZ), the RNA oncology...

MartinLutherKing 2 horas hace

All Aboard TTX Universal Solutions🚀🚀🚀
🚀🚀🚀🚀🚀🚀 Do your proper DD’G’s

https://ir.transcodetherapeutics.com/static-files/b0da9985-d5cc-43ef-823b-3a28eb8ee9d2

👍️0

MartinLutherKing 9 horas hace

The world is waiting for the billion dollar news

👍 1

zeusgodmd 9 horas hace

At 30 cents pre split we have some legs here

👍️0

MetaMonster 10 horas hace

The word is out on the streets, Shorts are all on the electric chair

👍️0

MartinLutherKing 10 horas hace

TRANSCODE’S TTX Universal Solution

👍️0

MartinLutherKing 10 horas hace

E Pluribus Unum brothers Do your proper DD G’s TTX The one and only company with an active clinical trial targeting mi-rna for the treatment of cancer

👍️0

Money hunt 14 horas hace

New presentation is out, embrace for RNA THERAPEUTICS
TO DELIVER A CANCER-FREE FUTURE

https://ir.transcodetherapeutics.com/news-and-events/presentations

👍 2 🔥 1 🚀 2

MetaMonster 1 día hace

It's time to execute the dirty rat short bastard motherfuckers for fucking all longs up the ass for years, The short rat bastards need to burn in hell,

👍️0

MetaMonster 1 día hace

Reddit Army, Roaring Kitty ready

👍️0

MetaMonster 1 día hace

The dirty rat shorts bastards of the earth will burn in hell for suppressing the only hope for terminally ill cancer patients while they put all long believers on the streets dirty motherfuckers,

👍️0

MetaMonster 1 día hace

The word is out in the White House, wallstreet speculation leads us to the one and only micro RNA TTX clinical trials with the FDA

👍️0

MetaMonster 1 día hace

Watch fox news video from 8 min 30 sec, The cancer sabotage for the terminally ill cancer patients is over, you short rat bastards motherfuckers are all going to hell

👍️0

Money hunt 2 días hace

Embrace for impact
BREAKING GROUND: Stargate, the massive artificial intelligence (AI) infrastructure project recently unveiled by President Donald Trump, has begun production in Texas — with data center construction in other states expected to be announced in the coming months.
https://www.foxnews.com/tech/ai-newsletter-trumps-stargate-ambitions.amp

👍️0

MartinLutherKing 4 días hace

Hello Germany https://oncologypro.esmo.org/meeting-resources/esmo-congress-2024/combination-treatment-with-ttx-030-a-first-in-class-anti-cd39-antibody-in-patients-with-advanced-pancreatic-cancer

👍️0

MartinLutherKing 4 días hace

Do your proper DD and you will see the light brother R&D Pipeline - Partnering Opportunities
TTX-siPDL1 has received Orphan Designation Status from FDA for pancreatic cancer.

https://www.transcodetherapeutics.com/other-products.html

👍️0

MetaMonster 4 días hace

The word is out on wall street, buyout

👍️0

MetaMonster 4 días hace

Open up the floodgates and unleash hell on earth on all short rats bastards that sabotaged the only hope for terminally ill cancer patients

👍️0

MetaMonster 4 días hace

The sabotage of the only hope for terminally ill cancer patients is over

👍️0

MartinLutherKing 4 días hace

Blast off and moon landing brothers with Trumps cure to cancer stargate

👍️0

MartinLutherKing 4 días hace

Take out the news Stargate TTX super power cure to cancer

👍️0

MartinLutherKing 4 días hace

The United States Of America Hails the holy grail of cancer research TTX Platform

👍️0

MartinLutherKing 4 días hace

100% Remission cure to cancer coming backed by stargate😁🚀🚀🚀

👍️0

MartinLutherKing 4 días hace

Cohort 1 demonstrated 66% inhibition of miR-10b at 24 hours post-infusion is already a breakthrough in the clinic. TTX-MC138 showed increased activity with dose escalation in Cohort 2, maintaining consistency across subsequent administrations

MartinLutherKing 4 días hace

Y’All Do your proper DD on TTX— Stargate material
https://www.transcodetherapeutics.com/delivery-platform.html

👍️0

tapioca 4 días hace

Holding 10’s on low daily volume, and wound tight..gonna blow soon..

👍️0

MetaMonster 4 días hace

New blood lurking waters, whale bite is imminent

👍️0

MetaMonster 4 días hace

The bastard rat shorts put all long believers on the streets and robbed them blindly, Rot in hell dirty rat motherfuckers

👍️0

MartinLutherKing 4 días hace

Cure to cancer moment🚀🚀🚀🚀

👍️0

MetaMonster 4 días hace

Rot in hell short rat bastards for shorting the only hope for terminally ill cancer patients TransCode Therapeutics Short Interest Data
TransCode Therapeutics (RNAZ) has a short interest of 368,300 shares, representing 55.73% of the float (the number of shares available for trading by the public). This marks a 355.25% increase in short interest from the previous month. The short interest ratio (days to cover) is 0.2, indicating that it would take 0.2 days of the average trading volume of 3.40 million shares to cover all short positions.

https://www.marketbeat.com/stocks/NASDAQ/RNAZ/short-interest/

👍️0

MartinLutherKing 4 días hace

Gut it out brothers, Weak hands are extinct

👍️0

MartinLutherKing 5 días hace

Let’s all hold hands and pray— hold for the cure to cancer moment 🚀🚀🚀🚀🚀

👍️0

MartinLutherKing 5 días hace

7.5M Market cap your call brothers, it’s no joke how undervalued the cure to cancer has been criminally abused by the shorts 🚀🚀🚀
Hold for gold🚀🚀🚀

👍️0

MartinLutherKing 5 días hace

Hold up the fort brothers strong hands in play, To the next level
KEY DATA
OPEN
$10.58
DAY RANGE
10.02 - 10.76
52 WEEK RANGE
2.66 - 66.33
MARKET CAP
$7.51M
SHARES OUTSTANDING
696.25K
PUBLIC FLOAT
660.86K

👍️0

MartinLutherKing 5 días hace

Hail TTX- The holy grail in cancer research
Inside Trump’s $500BILLION AI mega-project Stargate that could cure cancer, employ 100,000 & mark ‘dawn of golden age

https://www.thesun.co.uk/news/32943379/donald-trump-artificial-intelligence-stargate/amp/

👍️0

MartinLutherKing 5 días hace

Hello TTX WASHINGTON — President Trump unveiled a $500 billion artificial intelligence infrastructure project Tuesday at the White House alongside reps from three tech and investment giants — with those business leaders asserting the initiative could cure cancer.

OpenAI, SoftBank and Oracle launched the project, called Stargate, to unleash the new technology with the help of large data centers based in Texas.

“These world-leading technology giants are announcing the formation of Stargate,” Trump said. “So put that name down in your books, because I think you’re going to hear a lot about it in the future — a new American company that

https://nypost.com/2025/01/21/us-news/trump-announces-500b-ai-project-with-biz-titans-saying-it-can-cure-cancer/

👍️0

MartinLutherKing 5 días hace

Shorts calling the world to borrow,

👍️0

MartinLutherKing 5 días hace

TTX Will shock the world Cancer cure moment 🚀🚀🚀🚀

👍️0

Risk 5 días hace

We need some great news, hopefully soon. May be this qtr?

👍️0

MartinLutherKing 5 días hace

Let’s all hold hands and pray for the cure to cancer news tomorrow morning 🚀🚀🚀

👍 1

MetaMonster 5 días hace

Squeeze those motherfuckers to an all time high of $150,000 they sabotaged the only hope for terminally ill cancer patients

👍️0

MetaMonster 5 días hace

The short criminals sabotaged the only hope for terminally ill cancer patients for to long, They put all long believers on the streets,

👍️0

MartinLutherKing 5 días hace

E PLURIBUS UNUM BROTHERS TTX CURE TO CANCER 🚀🚀🚀🚀🚀
https://www.thefastmode.com/expert-opinion/39503-the-stargate-ai-project-america-s-500-billion-bet-but-at-what-cost

👍️0

MartinLutherKing 5 días hace

Last call all aboard🚀🚀🚀🚀🚀🚀🚀

👍️0

MartinLutherKing 5 días hace

The revolution in the clinic is here brothers, Billion dollar news is about to hit international wires.
https://www.msn.com/en-us/money/companies/softbank-outlines-500b-stargate-project-to-accelerate-ai-revolution/ar-AA1yUnWb

👍️0

MartinLutherKing 5 días hace

Start your engines The cure to cancer is coming

👍️0

MartinLutherKing 5 días hace

Trust me brother shorts are going to eat their own shit forcefully.

👍️0

MartinLutherKing 5 días hace

Let’s all pray for cancer cure news tomorrow morning 🚀🚀🚀🚀🚀

👍️0

Money hunt 5 días hace

Embrace yourselves for impact , 100K is very possible with all the reversal rates.

👍️0

Datos

Noticias

Herramientas

Mercados

Descubrir

Hot Features

Follow Feed

Flujo de Opciones

Monitor

TransCode Therapeutics Inc (RNAZ)

Discusiones en tiempo real e ideas comerciales: opere con confianza con nuestra poderosa plataforma.

RNAZ Noticias

Form 4 - Statement of changes in beneficial ownership of securities

Form 8-K/A - Current report: [Amend]

Form 8-K - Current report

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material

Nasdaq Determines That TransCode Therapeutics Has Regained Compliance with Continued Listing Requirements

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material

Form 8-K - Current report

TransCode Therapeutics Reports Positive Data from First-in-Human Clinical Study Using Novel Lead Therapeutic Candidate, TTX-MC138

Form DEFR14A - Revised definitive proxy soliciting materials

Form 8-K - Current report

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material

TransCode Therapeutics Open Letter to Shareholders

Form PRE 14A - Other preliminary proxy statements

Form 8-K - Current report

TransCode Therapeutics Announces FDA Clearance To Initiate Phase 1/2 Clinical Trial with TTX-MC138 in Patients with Advanced Solid Tumors

RNAZ Discussion

Su Consulta Reciente

Empresa

Negocios

Popular

Obtener la aplicación

Tendencias Ahora

Listas Principales

Datos

Noticias

Herramientas

Mercados

Descubrir

Hot Features

Follow Feed

Flujo de Opciones

Monitor

TransCode Therapeutics Inc (RNAZ) Noticias

TransCode Therapeutics Inc (RNAZ)

Discusiones en tiempo real e ideas comerciales: opere con confianza con nuestra poderosa plataforma.

RNAZ Noticias

Form 4 - Statement of changes in beneficial ownership of securities

Form 8-K/A - Current report: [Amend]

Form 8-K - Current report

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material

Nasdaq Determines That TransCode Therapeutics Has Regained Compliance with Continued Listing Requirements

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material

Form 8-K - Current report

TransCode Therapeutics Reports Positive Data from First-in-Human Clinical Study Using Novel Lead Therapeutic Candidate, TTX-MC138

Form DEFR14A - Revised definitive proxy soliciting materials

Form 8-K - Current report

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material

TransCode Therapeutics Open Letter to Shareholders

Form PRE 14A - Other preliminary proxy statements

Form 8-K - Current report

TransCode Therapeutics Announces FDA Clearance To Initiate Phase 1/2 Clinical Trial with TTX-MC138 in Patients with Advanced Solid Tumors

RNAZ Discussion

Su Consulta Reciente

Empresa

Negocios

Popular

Obtener la aplicación

Quitar anuncios